https://www.genengnews.com/topics/genome-editing/axovant-licenses-benitec-gene-therapy-candidates-for-opmd-neurological-disorders/
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025